
Western blot analysis of extracts from MCF-7 cells, untreated or treated with doxorubicin (0.5 μM, 36 h), doxorubicin followed by λ Phosphatase NEB#P0753 (10,000 Units/ml, 1 h), nocodazole (50 ng/ml, 36 h) or nocodazole followed by λ Phosphatase, using Phospho-Rpb1 CTD (Ser2/5) Antibody (upper) or p53 Antibody #9282 (lower).

Immunohistochemical analysis of paraffin-embedded human renal cell carcinoma, untreated (left) or λ phosphatase-treated (right), using Phospho-Rpb1 CTD (Ser2/5) Antibody.

Immunohistochemical analysis of paraffin-embedded human lung carcinoma, showing nuclear localization, using Phospho-Rpb1 CTD (Ser2/5) Antibody.

Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using Phospho-Rpb1 CTD (Ser2/5) Antibody in the presence of control peptide (left) or antigen-specific peptide (right).